(E)-N-(4-Chlorophenyl)-N'-propyl-3-(trifluoromethyl)benzene-1-carboximidamide

Catalog No. :
ACJMLY815
CAS No. :
303149-03-3
Molecular Formula :
C17H16ClF3N2
Molecular Weight :
340.78

IUPAC Name:N-(4-chlorophenyl)-N'-propyl-3-(trifluoromethyl)benzimidamide

(E)-N-(4-Chlorophenyl)-N'-propyl-3-(trifluoromethyl)benzene-1-carboximidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-N-(4-Chlorophenyl)-N'-propyl-3-(trifluoromethyl)benzene-1-carboximidamide
IUPAC NameN-(4-chlorophenyl)-N'-propyl-3-(trifluoromethyl)benzimidamide
MDL No.MFCD00172707
Molecular FormulaC17H16ClF3N2
Molecular Weight340.78
SMILESFC(C1=CC(/C(NC2=CC=C(Cl)C=C2)=N\CCC)=CC=C1)(F)F
InChI KeySPHJZMRRWPHPBV-UHFFFAOYSA-N
SynonymN-(4-CHLOROPHENYL)-N'-PROPYL-3-(TRIFLUOROMETHYL)BENZENECARBOXIMIDAMIDE;(E)-N-(4-chlorophenyl)-N'-propyl-3-(trifluoromethyl)benzene-1-carboximidamide;Benzenecarboximidamide, N-(4-chlorophenyl)-N'-propyl-3-(trifluoromethyl)-
CAS No.303149-03-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJMLY815 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGTAQ598 route compound structure diagram
    ACGTAQ598556-53-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJMLY815 route product structure diagram
    ACJMLY815303149-03-3
Inquiry

2. ACJMLY815 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJMLY815 route product structure diagram
    ACJMLY815303149-03-3
Inquiry

Comments (0)